“This workflow brings next-generation single-cell multiomics within reach of every lab,” said Suresh Pisharody, CEO of BioSkryb Genomics. “By reducing the need for complex cell sorting methods like ...

With three new partnerships, 10x Genomics signals a move beyond research tools toward clinical diagnostics using its single-cell and spatial biology platforms.

BioSkryb Genomics, a pioneer in single-cell and ultra–low-input multiomic solutions, together with Eremid ® Genomic Services, a specialty high-complexity genomics contract research organization and ...

PLEASANTON, Calif., Jan. 12, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Dana-Farber Cancer Institute to ...

The partners are launching ImmuneScape, a multiomics program using spatial and single-cell sequencing to study immune drivers ...

10x Genomics, Inc. (NASDAQ:TXG) is one of the best digital health stocks to buy now. On October 29, 2025, 10x Genomics announced the launch of its next-generation Chromium Flex assay, designed to help ...

In this discussion in GEN’s “The State of Multiomics and NGS” virtual summit, originally broadcast on April 23, 2025, Jonah Cool, PhD, Science Program Officer at CZI and Sarah Teichmann, PhD, Research ...

BioSkryb Genomics and Tecan Group (SIX Swiss Exchange: TECN), today introduced a high-throughput single-cell workflow, combining BioSkryb's 384-well format of the ResolveOME(TM) Whole Genome and ...

Combines BioSkyrb’s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384-well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflow Enables scalable, ...